Loading...
Adial Pharmaceuticals, Inc. WT EXP 073123
ADILW•NASDAQ
$0.001
$-0.00(-57.14%)
Adial Pharmaceuticals, Inc. WT EXP 073123 (ADILW) Stock Overview
Explore Adial Pharmaceuticals, Inc. WT EXP 073123’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
0.00%
Profit Growth
$-0.48
↓ 88.48%
EPS Growth
$-0.48
↑ 86.95%
Operating Margin
0.00%
↓ 20.27%
ROE
-218.88%
↓ 88.48%
Dividend Yield
0.00%
Analyst Recommendations data is not available for ADILWAnalyst Recommendations details for ADILW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
CEO
None
Headquarters
DE
Founded
2018